The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia

Aliment Pharmacol Ther. 1998 Aug;12(8):755-9. doi: 10.1046/j.1365-2036.1998.00369.x.

Abstract

Background: The electrogastrogram (EGG), which records gastric myoelectrical activity, is abnormal in one-third of adult patients with non-ulcer dyspepsia (NUD).

Aim: To observe the effects of cisapride on EGG in adults with NUD.

Methods: Twenty-seven NUD patients who had undergone a pre- and post-prandial EGG were entered into an open study. All patients completed a dyspepsia symptom questionnaire and were then treated with cisapride 10 mg t.d.s. The dyspepsia questionnaire was repeated in all those completing 4 weeks of treatment. Those with an initial abnormal EGG (< 70% of slow wave activity at 2-4 cycles per minute) had a repeat EGG at the end of the study.

Results: Treatment with cisapride was associated with a significant improvement in the post-prandial EGG (P = 0.007). After 4 weeks of treatment, 7 of 13 abnormal EGGs normalized. Symptom scores improved significantly in the 13 patients with an abnormal EGG who completed treatment (P < 0.0003), but not in NUD patients with a normal EGG (P = 0.48).

Conclusion: In this open study, treatment of NUD with cisapride was associated with significant symptom improvement in patients with an abnormal pre-treatment EGG, but not those with a normal EGG, with a significant improvement of the post-prandial EGG.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cisapride / pharmacology*
  • Dyspepsia / drug therapy*
  • Dyspepsia / physiopathology
  • Electromyography
  • Gastric Emptying / physiology*
  • Gastrointestinal Agents / pharmacology*
  • Humans
  • Postprandial Period
  • Stomach / drug effects
  • Stomach / physiopathology*
  • Treatment Outcome

Substances

  • Gastrointestinal Agents
  • Cisapride